Www.who.int/chp Launch of Global Alliance of Chronic Respiratory Diseases (GARD) Participants Organizations of GARD Eva Mantzouranis MD Chronic Respiratory.

Slides:



Advertisements
Similar presentations
G.W.Canonica GARD Bejing, March 28-29, 2006 Project for Allergy Diagnosis In Emerging Countries.
Advertisements

GARD Global Alliance against Chronic Respiratory Diseases WHO J Bousquet, R Dahl, N Khaltaev, HJ Bekedam.
Date: Saturday, April 28, 2007 Presented by: Carl C. Booberg Executive Director of the American Thoracic Society.
AGENDA 1.Welcome and note apologies by Theresa O’Keefe 2.Objectives of QSVN 3.Dates of meetings 4.ANZSVN conference details 5.Constitution 6.Election of.
1 LeTourneau University Tim Ochran, MS, DABR, Associate Professor of Radiation Oncology, UTHSCT January 26, 2011.
People want care. Where it comes from is secondary Breda Flood EFA President Athens, 24th May
“ Linking Blood Pressure and Cardiovascular Health” Welcome We invite you to explore what a membership in the American Society of Hypertension, Inc. (ASH)
NANN’s Mission NANN is the professional voice that shapes neonatal nursing through excellence in practice, education, research and professional development.
Turkish Thoracic Society: Who are we? Turkish Thoracic Society is a national, professional and scientific non-profit organization of specialists in Respiratory.
What is ABMS MOC™ Sheldon D. Horowitz, MD Special Advisor to the President
GARD - Country Initiatives BRAZIL Alvaro A. Cruz, M.D. Associate Professor of Universidade Federal da Bahia Scientist of CNPq - National Research Council.
Asthma What is Asthma ? V1.0 1997 Merck & ..
Report to IPCRG Family Physician Airways Group of Canada.
Statewide campaign to educate patients and physicians on important health topics: Choosing Wisely® ER is for Emergencies campaign Palliative care and end.
How to Overcome Barriers and Develop Collaborative Guidelines Amir Qaseem, MD, PhD, MHA, FACP Chair, Guidelines International Network Director, Clinical.
International Primary Care Respiratory Group working locally, collaborating globally.
Asthma Partnership Asthma in Mississippi Adults In 2004, 11.8% of Mississippi adults had ever had asthma (244,198 persons). In 2004, 7.1% of Mississippi.
Ms. Foster’s Disease Project Alcoholism Lung Cancer Obesity Skin Cancer Diabetes Type 1 Type 2 Allergies STDs Leukemia Whooping cough Breast Cancer Influenza.
GARD Steering committee report J Bousquet, R Dahl.
The Global Centre for Information and Communication Technologies in Parliament 14 June 2006 V Legislative XML Workshop Towards European Standards for Legislative.
Respiratory Care Understanding the Organizations that Serve Our Profession.
Collaboration Challenges: Inter- Organizational Guideline Forum (IOGF) Craig W. Robbins, MD, MPH KP Care Management Institute-Medical Director, Center.
Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases -
European Federation of Allergy and Airways Diseases Patients Associations Updates on Innovative Research for Allergy and Respiratory Disease in the European.
Targeting the respiratory nurse in primary care Practical and informative editorial Easy-to-read format Published quarterly The only journal specifically.
Global Alliance against Chronic Respiratory Diseases GARD/NCD Action Plan & 2011 UN Summit on NCDs Niels H. Chavannes MD PhD Associate.
Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases -
Presentation of EFA and Most Recent Activities David Brennan EU Policy and Programme Assistant
Establishing COPD Patient Organizations Mariadelaide Franchi, ICC Co-Chair, Italy Artwork by: Pierluigi Diano, Micaela Mau.
Burden of chronic diseases Giovanni Viegi, MD. Director of Research, Italian National Research Council. Head, Pulmonary Environmental Epidemiology Unit,
Respiratory Service Framework Asthma and COPD Care (Nursing) Project Learning and Development Strategy.
Report from GARD secretariat Nikolai Khaltaev, MD, PhD March 2006, GARD General Meeting, Beijing, China.
Chronic Diseases and Health Promotion – Global Alliance against Chronic Respiratory Diseases -
What China have done and will do since the GARD Launch Meeting held on March 28, 2006?
Chronic diseases of the airways Contents and tools for productive interactions between empowered patients and proactive professionals HMSP-IDSIM/SIM/0018/2009.
Klaus F. Rabe MD, PhD and the Challenges of Chronic Respiratory Disease...
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
ABOM Partner Organizations
Why buildings are key to achieve a better health in the EU?
Stephen Joseph Galli, MD  Journal of Allergy and Clinical Immunology 
European Respiratory Society
How does teamwork improve value. Dr Nils E
GARD/NCD Action Plan & 2011 UN Summit on NCDs
Sources: (1) Global Strategy for the diagnosis Management and Prevention of COPD, Global initiative for Chronic Obstructive Lung Disease (GOLD)
Pharmacologic rationale for treating allergic and nonallergic rhinitis
Asthma Phenotypes Defined From Parameters Obtained During Recovery From a Hospital-Treated Exacerbation  Rihuang Qiu, MD, Jiaxing Xie, MD, PhD, Kian Fan.
ČIPA – Czech Initiative for Asthma
Prevalence of true-positive, false-negative and false-positive cases of chronic obstructive pulmonary disease identified with the fixed-limit Global Initiative.
Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,
Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Asthma treatment and asthma prevention: A tale of 2 parallel pathways
Occurrence of morning symptoms
Smoking cessation rate as point prevalence quit rate from year 1 to 5 in the Lung Health Study with 5,587 chronic obstructive pulmonary disease patients.
A review of the current guidelines for allergic rhinitis and asthma
Biosimilars and drug development in allergic and immunologic diseases
3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).
A family-based pulmonary rehabilitation (PR) programme enhanced the coping resources of the families of chronic obstructive pulmonary disease patients.
Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with Common Variable Immunodeficiency  Phil Lieberman, MD, John Routes, MD  The Journal.
Advances in the approach to the patient with food allergy
E. Rand Sutherland, MD, MPH  Journal of Allergy and Clinical Immunology 
American Academy of Allergy, Asthma & Immunology
Screening test accuracy of the final risk score at a threshold of ≥2
Schematic diagram of the shared subgroups between asthma and chronic obstructive pulmonary disease (COPD). Schematic diagram of the shared subgroups between.
Clinical findings in patients with chronic obstructive pulmonary disease according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD)
Prevalence of chronic obstructive pulmonary disease (COPD) defined by different criteria by region. The dark grey bar represents ‘symptom-based COPD’,
Advances in pediatric asthma in 2007
Asthma, COPD, and overlap in a national cohort: ACO on a gradient
Stepwise approach for managing infants and young children (≤5 years old) with acute or chronic asthma. Stepwise approach for managing infants and young.
Presentation transcript:

Launch of Global Alliance of Chronic Respiratory Diseases (GARD) Participants Organizations of GARD Eva Mantzouranis MD Chronic Respiratory Diseases 28 March 2006

G A R D An alliance of 41 organizations, institutions and agencies focused on reducing the global burden of chronic respiratory diseases

G A R D

AAAAsthma and Allergy Association AAAAIAmerican Academy of Allergy, Asthma and Immunology AAAFAsian Allergy and Asthma Foundation ACAAIAmerican College of Allergy, Asthma and Immunology AIMARInterdisciplinary Association for Research in Lung Disease ALATLatin American Thoracic Society APAACIAsia Pacific Association of Allergology and Clinical Immunology APSRAsian Pacific Society of Respirology ARIAAllergic Rhinitis and its impact on Asthma ATSAmerican Thoracic Society CNRItalian National Research Council - Institute of Neurobiology and Molecular Medicine Research Area Tor Vergata DLHADanish Lung Health Association DU-WCCDokkyo University WHO Collaborating Centre GARD PARTICIPANTS (1)

EAACIEuropean Academy of Allergy and Clinical Immunology ECARFEuropean Centre for Allergy Research Foundation EFAEuropean Federation of Allergy and Airways Diseases Patients' Associations ERSEuropean Respiratory Society FEMTECWorld Federation of Hydrotherapy and Climatotherapy FILHAFinnish Lung Health Association FIRSForum of the International Respiratory Societies GA2LENGlobal Allergy and Asthma European Network GINAGlobal Initiative for Asthma GOLDGlobal Initiative for Chronic Obstructive Pulmonary Disease GU-WCCGhent University WHO Collaborating Centre ICCInternational Coalition for COPD InterasmaInternational Association of Asthmology IPCRGInternational Primary Care Respiratory Group GARD PARTICIPANTS (2)

IPRAISInternat. Pediatric Respiaratory and Allergies Immunological Societies IRCCSIRCCS San Raffaele, Italy IUATLDInternational Union Against Tubercolosis and Lung Diseases KAAFKorea Asthma Allergy Foundation KTLNational Public Health Institute, Finland NHLBINational Hearth Lung and Blood Institute, USA PSAPolish Society of Allergology RSPRussian Association of Pulmonologists SFAICSociété Française d’Allergologie et d’Immunologie Clinique SPAICPortuguese Society of Allergology and Clinical Immunology SPLFSociété de Pneumologie de Langue française TTSTurkish Thoracic Society WAOWorld Allergy Organization WONCAWorld Organization of Family Doctors GARD PARTICIPANTS (3)

GARD Participants Name of Organizati on Year established Journal and Website address Mission Category (Int.Org./N GO/etc.) Interest sections or assemblies No. of members/part ners and representation by WHO Region GARD PARTICIPANTS' TEMPLATE

GARD PARTICIPANTS Established between 1907( FILHA) and 2004 (GA2LEN, AAAF) Number of Members of each organization vary between ,000

GARD Organizations' Mission To prevent and treat respiratory diseases.. To advance the knowledge for optimal patient care.. and better quality of life To promote research, foster education, exchange knowledge,.. increase awareness, …spread excellence To interact with organizations that have similar goals

AAA AAAI AAAF ACAAI APAACI EAACI ECARF EFA GA2LEN IPRAIS IRCCS KAAF PSA SFAIC SPAIC WAO AIMAR ALAT APSR ATS DLA DOKKYO ERS FILHA FIRS GU-WCC ICC NHLBI RSP SPLF TTS UNION CNR FEMTEC IPCRG KTL WONCA ARIA INTERASMA GINA GOLD AllergicThoracicPrimary CareDiseases Specific GARD Organizations: Specialties

EFA, ICC

CNR, KTL, NHBLI,

International ARIA AAAAI ATS ERS FEMTEC FIRS GINA GOLD ICC INTERASMA IPCRG IPRAIS UNION WAO WONCA RegionalNational AAAF APAACI APSR ALAT EFA EAACI GA2LEN AAA ACAAI AIMAR CNR DLA DOKKYO ECARF FILHA IRCCS KAAF KTL NHLBI PSA RSP SFAIC SPAIC SPLF TTS GARD Organizations

GARD Dokkyo University School of Medicine IRCCS CNR KAAF SFAIC RSPFIRS AAA IPCRG IPRAIS

Allergic Regional Thoracic Non Governmental Patients' Public Health Governmental National G A R D Disease oriented Inter national Pediatric Other?

Allergic Regional Thoracic Non Governmental Patients' Public Health Governmental National G A R D Disease oriented Inter national Pediatric Other? Together we can make it